CCR5 delta32の関連性は,喘息のリスクの低下と関連している
Lancet (London, England)
|October 16, 1999
まとめ
CCR5 delta32変異を有する個人は,喘息を発症するリスクが低い. この発見は,この遺伝子変異の集団における一般的な発生を説明する可能性がある.
科学分野:
- 免疫学 免疫学とは
- 遺伝学 遺伝学とは
- 呼吸器医学とは
背景:
- C-Cケモカイン受容体5 (CCR5) は,免疫反応において重要な役割を果たしています.
- CCR5 delta32変異は,ヒト集団で見られる既知の遺伝子変異種です.
研究 の 目的:
- CCR5デルタ32変異と喘息のリスクとの関連を調査する.
- CCR5 delta32変異の流行に関する潜在的な説明を探求する.
主な方法:
- CCR5デルタ32変異の個体の遺伝子分析.
- 変異状態に関連した喘息の流行病学的評価.
主要な成果:
- 統計的に有意な喘息リスクの減少は,CCR5 delta32変異を持つ個体で観察されました.
- 変異の喘息に対する保護効果が特定されました.
結論:
- CCR5デルタ32変異は,喘息発症に対するある程度の保護を与えます.
- この保護的関連は,突然変異の流行に対する潜在的な進化的説明を提供します.
関連する概念動画
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


